Back to Search
Start Over
TCTAP A-003 First-in-human Evaluation of a Novel Poly-L-lactide Based Sirolimus-eluting Bioresorbable Vascular Scaffold for the Treatment of De Novo Native Coronary Artery Lesions: MeRes-1 Trial
- Source :
- Journal of the American College of Cardiology. 69:S2
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
-
Abstract
- The life-long presence of the metallic prosthesis interferes with the restoration of vasomotion and restricts quality lesion imaging during repeat surgical or percutaneous treatment. As a solution to this, we assessed safety and efficacy of a novel Poly-L-Lactide based Sirolimus-eluting
- Subjects :
- medicine.medical_specialty
Percutaneous
business.industry
medicine.medical_treatment
Vasomotion
First in human
Prosthesis
Surgery
Lesion
medicine.anatomical_structure
Sirolimus
Medicine
medicine.symptom
Cardiology and Cardiovascular Medicine
business
medicine.drug
Bioresorbable vascular scaffold
Artery
Subjects
Details
- ISSN :
- 07351097
- Volume :
- 69
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi...........5914cd82a16a85c2d51c133aa0d4fce7